Welcome to LookChem.com Sign In|Join Free
  • or
(3-FORMYL-INDOL-1-YL)-ACETIC ACID ETHYL ESTER is a chemical compound that belongs to the class of indole derivatives. It is an ester of acetic acid and contains a formyl group attached to the indole ring. This unique structure endows it with potential biological activities, making it a significant compound in the field of organic chemistry and drug discovery.

27065-94-7

Post Buying Request

27065-94-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

27065-94-7 Usage

Uses

Used in Pharmaceutical and Medicinal Chemistry:
(3-FORMYL-INDOL-1-YL)-ACETIC ACID ETHYL ESTER is used as a potential candidate for drug development due to its promising antioxidant, antimicrobial, and anti-inflammatory properties. Its unique structure and potential biological activities make it a valuable compound for research and development in the pharmaceutical and medicinal chemistry industries.
Used in Antioxidant Applications:
(3-FORMYL-INDOL-1-YL)-ACETIC ACID ETHYL ESTER is used as an antioxidant agent for its ability to protect cells from oxidative damage, which is a significant factor in various diseases and aging processes.
Used in Antimicrobial Applications:
(3-FORMYL-INDOL-1-YL)-ACETIC ACID ETHYL ESTER is used as an antimicrobial agent for its potential to inhibit the growth of harmful microorganisms, making it a valuable compound in the development of new antibiotics and antimicrobial treatments.
Used in Anti-inflammatory Applications:
(3-FORMYL-INDOL-1-YL)-ACETIC ACID ETHYL ESTER is used as an anti-inflammatory agent for its potential to reduce inflammation and alleviate symptoms associated with inflammatory conditions, offering a new avenue for the treatment of various inflammatory diseases.

Check Digit Verification of cas no

The CAS Registry Mumber 27065-94-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,0,6 and 5 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 27065-94:
(7*2)+(6*7)+(5*0)+(4*6)+(3*5)+(2*9)+(1*4)=117
117 % 10 = 7
So 27065-94-7 is a valid CAS Registry Number.
InChI:InChI=1/C13H13NO3/c1-2-17-13(16)8-14-7-10(9-15)11-5-3-4-6-12(11)14/h3-7,9H,2,8H2,1H3

27065-94-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (3-Formyl-indol-1-yl)-acetic acid ethyl ester

1.2 Other means of identification

Product number -
Other names ethyl 2-(3-formylindol-1-yl)acetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27065-94-7 SDS

27065-94-7Relevant academic research and scientific papers

Phenanthro [9,10-d] imidazole derivatives containing indoles as well as synthesis and application of phenanthro [9,10-d] imidazole derivatives containing indoles

-

Paragraph 0017; 0018; 0019, (2017/08/23)

The invention discloses phenanthro [9,10-d] imidazole derivatives containing indoles as well as a preparation method and application of the phenanthro [9,10-d] imidazole derivatives containing the indoles and belongs to the field of biological organic synthesis. The phenanthro [9,10-d] imidazole derivatives containing the indoles, disclosed by the invention, are characterized in that an indole pharmacophore with anticancer activity is introduced on phenanthro imidazole to increase conjugate area and improve biological activities of molecules, thereby improving an antitumor effect. The preparation method of the phenanthro [9,10-d] imidazole derivatives containing the indoles, disclosed by the invention, is characterized in that by taking indole-3-formaldehyde as a starting point, different chains (halides) are modified at N-positions, and are finally condensed with 9,10-phenanthrenequinone to synthesize the phenanthro [9,10-d] imidazole derivatives containing the indoles which have a restraining force for the growth of tumor cells in vitro.

Supported TBD-assisted solution phase diversification of formyl-aza-heterocycles through alkylation-knoevenagel one pot sequences

Maatougui, Abdelaziz El,Crespo, Abel,Silva, Artur M.S.,Coelho, Alberto

experimental part, p. 570 - 582 (2012/07/31)

An efficient solution-phase parallel procedure to perform the structural diversification of some formyl-nitrogen heterocycles (A) using the reusable TBD supported base is described. The library synthesis is based in a consecutive Alkylation-Knoevenagel functionalisation that uses alkyl halides (B), Michael acceptors (C) and activated methylene compounds (D) as diversity elements.

Solid-liquid phase alkylation of n-heterocycles: Microwave-assisted synthesis as an environmentally friendly alternative

Milen, Matyas,Gruen, Alajos,Balint, Erika,Dancso, Andras,Keglevich, Gyoergy

experimental part, p. 2291 - 2301 (2010/09/17)

The solid-liquid phase alkylation of a variety of five-membered N-heterocycles (carbazole, imidazole, benzimidazole, and indole-3-carbaldehyde) was carried out under different conditions. The use of alkali carbonate in dimethylformamide or in MeCN (in the latter case, in the presence of a phase-transfer catalyst) is a suitable method to prepare the corresponding N-alkylated products in an efficient way. In most cases, the solventless, microwave-assisted reaction is an environmentally friendly alternative to traditional methods. Copyrigh

ORGANIC COMPOUNDS

-

Page/Page column 162-163, (2008/06/13)

3,4-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; the use of a compound of that cla

3,4,(5)-SUBSTITUTED TETRAHVDROPYRIDINES

-

Page/Page column 162-163, (2008/06/13)

Organic Compounds 3,4(,5)-substituted tetrahydropyridine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4(,5)- substituted tetrahydropyridine compound, and/or a method of treatment comprising administering a 3,4(,5)-substituted tetrahydropyridine compound, a method for the manufacture of a 3,4(,5)- substituted tetrahydropyridine compound, and novel intermediates and partial steps for its synthesis. The 3,4(,5)- substituted tetrahydropyridine compounds have the formula I wherein the substituents and symbols are as described in the specification.

PHARMACEUTICAL PREPARATIONS COMPRISING INSULIN, ZINC IONS AND A ZINC-BINDING LIGAND

-

Page/Page column 229-230, (2008/06/13)

Novel preparations comprising branched ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The preparations have a prolonged action designed for flexible injection regimes.

PHAMACEUTICAL PREPARATIONS COMPRISING INSULIN

-

Page/Page column 224-225, (2010/02/15)

Novel preparations comprising ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer wherein the ligand is extended by protamine that are capable of prolonging the ac-tion of insulin preparations.

Efficient consecutive alkylation-Knoevenagel functionalisations in formyl aza-heterocycles using supported organic bases

Coelho, Alberto,El-Maatougui, Abdelaziz,Ravi?a, Enrique,Cavaleiro, José A. S.,Silva, Artur M. S.

, p. 3324 - 3328 (2008/09/17)

An efficient solution-phase parallel procedure to perform the structural diversification of some formyl aza-heterocycles employing supported organic bases (PS-BEMP, PS-TBD or Si-TBD) is described. The library synthesis is based on a consecutive alkylation-Knoevenagel functionalisation that employs alkyl halides, Michael acceptors, and malonic acid derivatives as diversity elements. Georg Thieme Verlag Stuttgart.

Stabilised insulin compositions

-

Page/Page column 120, (2008/06/13)

The present invention provides pharmaceutical compositions comprising insulin and novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The resulting preparations have improved physical and chemical stability.

PHARMACEUTICAL PREPARATIONS COMPRISING ACID-STABILISED INSULIN

-

Page/Page column 225-226, (2010/02/08)

Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 27065-94-7